In vitro antimalarial activity of retinoids and the influence of selective retinoic acid receptor antagonists

Acta Tropica

Volumn 87, Issue 3, 2003, Pages 345-353

  Hamzah, J ^a   Skinner Adams, T S ^a   Davis, T M E ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

3H hypoxanthine; Isobolographic analysis; Plasmodium falciparum; Retinoic acid; Retinoic acid receptor antagonist; Retinol; Retinyl palmitate

Indexed keywords

AGN 194301; ALITRETINOIN; ER 27191; HYPOXANTHINE; ISOTRETINOIN; RECEPTOR BLOCKING AGENT; RETINOIC ACID RECEPTOR; RETINOIC ACID RECEPTOR BLOCKING AGENT; RETINOID DERIVATIVE; RETINOL; RETINOL PALMITATE; RO 415253; TRITIUM; UNCLASSIFIED DRUG;

MALARIA;

ANTIMALARIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; GROWTH INHIBITION; IC 50; MATHEMATICAL ANALYSIS; MATHEMATICAL COMPUTING; NONHUMAN; PLASMODIUM FALCIPARUM; STRAIN IDENTIFICATION;

PLASMODIUM FALCIPARUM;

EID: 0142026987     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-706X(03)00119-0     Document Type: Article

References (48)

1. Achkar C.C., Derguini F., Blumberg B., Langston A., Levin A.A., Speck J., Evans R.M., Bolado J. Jr., Nakanishi K., Buck J. 4-Oxoretinol, a new natural ligand and transactivator of the retinoic acid receptors. Proc. Natl. Acad. Sci. 93:1996;4879-4884.
2. Allenby G., Bocquel M.T., Sounders M., Kazmer S., Speck J., Rosenberger M., Lovey A., Kastner P., Grippo J.F., Chambon P., Levin A.A. Retinoic acid receptors and retinoid X receptors: interaction with endogenous retinoic acids. Proc.Natl. Acad. Sci. 90:1993;30-34.
3. Apfel C.M., Bauer F., Crettaz M., Forni L., Kamber M., Kaufmann F., LeMotte P., Pirson W., Klaus M. A retinoic acid receptor antagonist selectively counteracts retinoic acid effects. Proc. Natl. Acad. Sci. 89:1992;7129-7133.
4. Berenbaum M.C. A method for testing for synergy with any number of agents. J. Inf. Dis. 137:1978;122-130.
5. Brueckner R.P., Fleckenstein L. Simultaneous modeling of the pharmacokinetics and methemoglobin pharmacodynamics of an 8-aminoquinoline candidate antimalarial (WR 238605). Pharm. Res. 8:1991;1505-1510.
6. Canfield C.J., Pudney M., Gutteridge W.E. Interactions of atovaquone with other antimalarial drugs against P. falciparum in vitro. Exp. Parasitol. 80:1995;373-381.
7. 3H]-hypoxanthine incorporation. Exp. Parasitol. 55:1983;138-146.
8. Clark I.A., Chaudhri G., Cowden W.B. Some roles of free radicals in malaria. Free. Radic. Biol. Med. 6:1989;315-321.
9. Czarniecki C.W., Fennie C.W., Powers D.B., Este D.A. Synergistic antiviral and antiproliferative activities of Escherichia coli-derived human alpha, beta, and gamma interferons. J. Virol. 49:1984;490-496.
10. Davis T.M.E., Garcia-Webb P., Fu L., Spencer J.L., Beilby J., Guo X. Antioxidant vitamins in acute malaria. Trans. Roy. Soc. Trop. Med. Hyg. 87:1993;596-597.
11. Davis T.M.E., Binth T.Q., Danh P.T., Dyer J.R., John A.S., Garcia-Webb P., Anh T.K. Serum vitamin A and E concentrations in acute falciparum malaria: modulators or markers of severity. Clin. Sci. 87:1994;505-511.
12. Davis T.M.E., Skinner-Adams T.S., Beilby J. In vitro growth inhibition of P. falciparum by retinol at concentrations present in normal human serum. Acta Trop. 69:1998;111-119.
13. Davis T.M.E., Binh T.Q., Thu L.T.A., Rossi R., Danh P.T., Barrett P.H.R., Beilby J. Pharmacokinetics of retinyl palmitate and retinol after intramuscular retinyl palmitate administration in severe malaria. Clin. Sci. 99:2000;433-441.
14. Dawson M.I., Elstner E., Kizaki M., Chen D.L., Pakkala S., Kerner B., Koeffler P.H. Myeloid differentiation mediated through retinoic acid receptor/retinoic X receptor (RXR) not RXR/RXR pathway. Blood. 84:1994;446-452.
15. Ferrari N., Agradi E., Vidali G. Effect of retinol on macromolecular synthesis in cultured cell lines. Acta Vitaminol. Enzymol. 5:1983;119-124.
16. Forman B.M., Umesono K., Chen J., Evans R.M. Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell. 81:1995;541-550.
17. Freebern W.J., Niles E.G., Loverde P.T. RXR-2, a member of the retinoid X receptor family in Schistosoma mansoni. Gene. 233:1999;33-38.
18. Freebern W.J., Osman A., Niles E.G., Christen L., LoVerde P.T. Identification of a cDNA encoding a retinoid X receptor homologue from Schistosoma mansoni. J. Biol. Chem. 274:1999b;4577-4585.
19. Geary T.G., Divo A.D., Jensen J.B., Zangwill M., Ginsburg H. Kinetic modelling of the response of P. falciparum to chloroquine and its experimental testing in vitro. Biochem. Pharmacol. 40:1990;685-691.
20. Giguere V., Ong E.S., Segui P., Evans R.M. Identification of a receptor for the morphogen retinoic acid. Nature. 330:1987;624-629.
21. Glass C.K. Some new twist in the regulation of gene expression by thyroid hormone and retinoic acid receptors. J. Endocrinol. 150:1996;349-357.
22. Guo X., Xu Q., Harmon M.A., Jin X., Laudet V., Mangelsdorf D.J., Palmer M.J. Isolation of two functional retinoid X receptor subtypes from the ixodid tick, Amblyomma americanum (L.). Mol. Cell. Endocrinol. 139:1998;45-60.
23. Hautvast J.L., Tolboom J.J., West C.E., Kafwembe E.M., Sauerwein R.W., Staveren W.A.v. Malaria is associated with reduced serum retinol levels in rural Zambian children. Int. J. Vitam. Nutr. Res. 68:1998;384-388.
24. Heyman R.A., Mangelsdorf D.J., Dyck J.A., Stein R.B., Eichele G., Evans R.M., Thaller C. 9-Cis-retinoic acid is a high affinity ligand for the retinoid X receptor. Cell. 68:1992;397-406.
25. 50 in studies of drug resistance of malaria parasites. Acta Trop. 55:1993;257-261.
26. Klaassen I., Brakenhoff R.H., Smeets S.J., Snow G.B., Braakhuis B.J.M. Considerations for in vitro retinoid experiments: importance of protein interaction. Biochim. Biophys. Acta. 1427:1999;265-275.
27. Kochhar D.M., Jiang H., Penner J.D., Johnson A.T., Chandraratna R.A.S. The use of a retinoid receptor antagonist in a new model to study vitamin-A dependent events. Int. J. Dev. Biol. 42:1998;601-608.
28. Kurokawa R., Direnzo J., Boehm M., Sugarman J.B., Gloss B., Rosenfeld M.G., Heyman R.A., Glass C.K. Regulation of retinoid signalling by receptor polarity and allosteric control of ligand binding. Nature. 371:1994;528-531.
29. Leid M., Kastner P., Chambon P. Multiplicity generates diversity in the retinoic acid signalling pathway. Trends Biochem. Sci. 17:1992;427-433.
30. Levander O.A., Ager A.L. Malarial parasites and antioxidant nutrients. Parasitology. 107:1993;95-106.
31. Levin A.A., Sturzenbecker L.J., Kazmer S., Bosakowski T., Huselton C., Allenby G., Speck J., Kratzeisen C., Rosenberger M., Lovey A., et al. 9-Cis-retinoic acid stereoisomer binds and activates the nuclear receptor RXR alpha. Nature. 355:1992;359-361.
32. Mangelsdorf D.J., Ong E.S., Dyck J.A., Evans R.M. Nuclear receptor that identifies a novel retinoic acid response pathway. Nature. 345:1990;224-229.
33. Perera S.C., Palli S.R., Ladd T.R., Krell P.J., Retnakaran A. The ultraspiracle gene of the spruce budworm, Choristoneura fumiferana: cloning of cDNA and developmental expression of mRNA. Dev. Genet. 22:1998;169-179.
34. Petkovich M., Brand N.J., Krust A., Chambon P. A human retinoic acid receptor which belongs to the family of nuclear receptor. Nature. 330:1987;444-450.
35. Poch G. Dose factor of potentiation derived from isobologram. Drug Res. 30:1980;2195-2196.
36. Repa J.J., Hanson K.K., Clagett-Dame M. All-trans-retinol is a ligand for the retinoic acid receptors. Proc.Natl. Acad. Sci. 90:1993;7293-7297.
37. Rosenblum M.G. Biochemical effects of human interferon in combination with difluromethylorinithine on human lymphoblastoid (DAUDI) cells in culture. Lymphokine Cytok. Res. 10:1991;83-87.
38. Schapira M., Raaka B.M., Samuels H.H., Abagyan R. Rational discovery of novel nuclear hormone receptor antagonists. PNAS. 97:2000;1008-1013.
39. Schwartz J.L. The dual roles of nutrients as antioxidants and prooxidants: their effects on tumor cell growth. Cancer Cell Res. Anti- or Pro-oxidants. 1996;1221S-1227S.
40. Shankar A.H., Genton B., Semba R.D., Baisor M., Paino J., Tamja S., Adiguma T., Wu L., Rare L., Tielsch J.M., Alpers M.P., West J.K.P. Vitamin A supplementation is a cost effective intervention for reducing malaria morbidity. Evidence-based Healthcare. 4:2000;5.
41. Skinner-Adams T., Davis T.M.E., Barrett H. Heterogeneous activity in vitro of vitamin A (retinol) in combination with novel and established antimalarial drugs. Trans. Roy. Soc. Trop. Med. Hyg. 93:1999;550-551.
42. Sluder A.E., Methews S.W., Hough D., Yin V.P., Maina C.V. The nuclear receptor superfamily has undergone extensive proliferation and diversification in nematodes. Genome Res. 9:1999;103-120.
43. Sturchler D., Tanner M., Hanck A., Betschart B., Gautschi K., Weiss N., Burnier E., Giudice G.D., Degremont A. A longitudinal study of the relations of retinol with parasitic infections and the immune response in children of Kikwawila village, Tanzania. Acta Trop. 44:1987;213-227.
44. Teng M., Duong T.T., Johnson A.T., Klein E.S., Wang L., Khalifa B., Chandraratna R.A.S. Identification of highly potent retinoic acid receptor a-selective antagonists. J. Med. Chem. 40:1997;2445-2451.
45. Trager W., Jensen J.B. Human malaria parasites in continuous culture. Science. 193:1976;673-675.
46. Tsai M.J., O'Malley B.W. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu. Rev. Biochem. 63:1994;451-486.
47. Ueno H., Kizaki M., Matsushita H., Muto A., Yamato K., Nishihara T., Hida T., Yoshimura H., Koeffler H.P., Ikeda Y. A novel retinoic acid receptor (RAR)-selective antagonist inhibits differentiation and apoptosis of HL-60 cells: implications of RAR α-mediated signals in myeloid leukemic cells. Leukemia Res. 22:1998;517-525.
48. Zhang X.K., Kehman J., Hoffmann B., Dawson M.F., Cameron J., Groupner G. Retinoid X receptor is an auxillary protein for thyroid hormone and retinoic acid receptors. Nature. 358:1992;587-591.